BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Viatris to Present at the BofA Securities 2025 Healthcare Conference

  April 25, 2025

   · 

  1 min read
• Press Releases

  Avantor® Reports First Quarter 2025 Results

  April 25, 2025

   · 

  18 min read
• Press Releases

  Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

  April 25, 2025

   · 

  1 min read
• Press Releases

  Travere Therapeutics to Report First Quarter 2025 Financial Results

  April 25, 2025

   · 

  1 min read
• Press Releases

  Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma

  April 25, 2025

   · 

  6 min read
• Press Releases

  Vistin Pharma ASA: First quarter 2025 financial results

  April 25, 2025

   · 

  1 min read
• Press Releases

  TREMFYA® (guselkumab) receives European Commission approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease

  April 25, 2025

   · 

  14 min read
• Press Releases

  InnoCare Announces Approval of Orelabrutinib for the First-line Treatment of CLL/SLL in China

  April 25, 2025

   · 

  4 min read
• Press Releases

  Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda

  April 25, 2025

   · 

  2 min read
• Press Releases

  Topas Therapeutics Announces Presentation of Phase 2a Data for TPM502 in Celiac Disease at Digestive Disease Week® 2025 in San Diego

  April 25, 2025

   · 

  2 min read